According to a new FMI report, the global Needle-free Injectors Market Demand will develop at a 12% CAGR between 2022 and 2032. By the end of the assessment period, the market is expected to be worth US$ 42.79 billion. Faster drug delivery is the primary driver of the needle-free injector business. Increased demand in the healthcare business, as well as expansion in cosmetic procedures, are driving the growing demand for Needle-free Injectors.
The industry grew significantly from 2017 to 2021, with an 8% value CAGR and a total value of US$ 12.3 billion. The use of technologically advanced spring-loaded jet injectors is driving market growth. Furthermore, regulatory approvals to increase the use of Needle-free Injectors are driving up demand.
For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-13960
Geographically, the United States is the largest contributor to the market for Needle-free Injectors. This is because chronic diseases are becoming more prevalent in the region. The existence of healthcare sectors in Germany, Japan, and China hastened the adoption of Needle-free Injectors even more. Needle-free Injector sales will increase in the coming years due to the increased inclination for minimally invasive procedures.
Key Takeaways from the Market Study
- During the forecast period, the projectile injections load type sector is expected to develop at a CAGR of 13.9%.
- In terms of technology, spring-loaded jet injectors will lead the market, accounting for 47.1% of sales in 2022.
- Drug delivery is expected to be the market leader by application, accounting for 65.0% of revenue in 2022.
- In 2022, reusable needle-free injectors are expected to dominate the market, accounting for 79.5% of sales.
- Throughout the projection period, hospitals are expected to remain the leading end-user, accounting for more than 33.4% of the market.
- The United States is expected to be the largest market in North America in 2022, accounting for more than 94.0% of the market.
- Germany is expected to dominate the Europe, holding 29.4% Europe’s market share through 2032
- Japan is projected to hold over 34% share in the East Asia market, exhibiting growth at a CAGR of 11.7% during the forecast period
- China led the East Asia market with more than 46.8% share and is projected to expand at a CAGR of 12.0% through 2032.
“The healthcare sector along with the cosmetic industry are the largest contributors to Needle-free Injectors market. Increasing demand for minimally-invasive surgeries is further accelerating the demand for Needle-free Injectors” states an FMI analyst
Ask Us Your Questions About This Report@ https://www.futuremarketinsights.com/ask-question/rep-gb-13960
Market Competition
Key players in the Needle-free Injectors market are Gerresheimer AG, Pfizer Inc., Antares Pharma, CSL Limited (Seqirus UK Limited), Crossject, Portal Instruments, Ferring Pharmaceuticals, PharmaJet Inc., PenJet Corporation
- The University of Adelaide commenced the human trial of omicron COVID vaccination booster using Pharma-Jet needle-free technology in August 2022. Furthermore, the vaccines were administered utilising the PharmaJet Tropis NFIS.
- Portal Instruments, a global leader in Needle-free Injectors, is working on developing Needle-free Injectors for various chronic conditions as well as raising awareness about painless injections.
Key Segments Profiled In The Needle-free Injectors Market Industry Survey
Needle-free Injectors Market by Load:
- Needle-free Injectors by Liquid Injections
- Needle-free Injectors by Powder Injections
- Needle-free Injectors by Projectile Injections
Needle-free Injectors Market by Technology:
- Needle-free Injectors by Spring-loaded jet injector
- Needle-free Injectors by Battery-powered jet injector
- Needle-free Injectors by Gas-powered jet injector
Needle-free Injectors Market by Delivery Site:
- Needle-free Injectors by Intra dermal injectors
- Needle-free Injectors by Intramuscular injectors
- Needle-free Injectors by Subcutaneous injectors
Needle-free Injectors Market by Application:
- Needle-free Injectors by Drug Delivery
- Needle-free Injectors by Vaccines
- Needle-free Injectors by Cosmetic
- Needle-free Injectors by Others
Needle-free Injectors Market by End User:
- Needle-free Injectors by Home Care Settings
- Needle-free Injectors by Long Term Care Centers
Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/13960
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs